Automate Your Wheel Strategy on YI
With Tiblio's Option Bot, you can configure your own wheel strategy including YI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol YI
- Rev/Share 833.6101
- Book/Share 22.0402
- PB -0.7876
- Debt/Equity -0.3996
- CurrentRatio 1.1311
- ROIC 0.0033
- MktCap 507882487.4658
- FreeCF/Share 14.3448
- PFCF 2.0494
- PE -7.8178
- Debt/Assets 0.0921
- DivYield 0
- ROE 0.1044
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Published: March 20, 2025 by: PRNewsWire
Sentiment: Neutral
Achieved First-Ever Annual Operating Profit Bottom Line Improved by RMB332.7 Million YoY in 2024 Operating Expenses as a Percentage of Revenues Decreased 230 Basis Points YoY in 2024 Q4'24 Operating Expenses as a Percentage of Revenues Decreased 470 Basis Points YoY Achieved First-Ever Annual Positive Operating Cash Flow SHANGHAI , March 20, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the fourth quarter and fiscal year …
Read More
111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow
Published: February 20, 2025 by: PRNewsWire
Sentiment: Neutral
SHANGHAI , Feb. 20, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2024 ended December 31, 2024, before the U.S. market opens on Thursday, March 20, 2025. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 20, 2025 (7:30 PM Beijing Time on the same day).
Read More
111, Inc. Regains Compliance with NASDAQ Requirement
Published: February 11, 2025 by: PRNewsWire
Sentiment: Neutral
SHANGHAI , Feb. 11, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, announced today that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") on February 10, 2025, confirming that Nasdaq has determined that for the last ten consecutive business days, from January 24, 2025 to February 7, 2025, the closing bid price of the Company's American Depositary Shares has been at $1.00 per share or greater. Accordingly, the Company has …
Read More
About 111, Inc. (YI)
- IPO Date 2018-09-12
- Website https://www.111.com.cn
- Industry Medical - Pharmaceuticals
- CEO Mr. Junling Liu
- Employees 1238